BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 28076672)

  • 1. Prenatal Psychostimulant and Antidepressant Exposure and Risk of Hypertensive Disorders of Pregnancy.
    Newport DJ; Hostetter AL; Juul SH; Porterfield SM; Knight BT; Stowe ZN
    J Clin Psychiatry; 2016 Nov; 77(11):1538-1545. PubMed ID: 28076672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association between mental illness, psychotropic medication use and hypertensive disorders in pregnancy: A multicentre study.
    Frayne J; Watson S; Snellen M; Nguyen T; Galbally M
    Pregnancy Hypertens; 2021 Jun; 24():22-26. PubMed ID: 33636509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of Hypertensive Disorders of Pregnancy in Women Treated With Serotonin-Norepinephrine Reuptake Inhibitors: A Comparative Study Using the EFEMERIS Database.
    Benevent J; Araujo M; Karki S; Delarue-Hurault C; Waser J; Lacroix I; Tebeka S; Damase-Michel C
    J Clin Psychiatry; 2023 Jul; 84(4):. PubMed ID: 37437238
    [No Abstract]   [Full Text] [Related]  

  • 4. Antidepressant use during pregnancy and the risk of major congenital malformations in a cohort of depressed pregnant women: an updated analysis of the Quebec Pregnancy Cohort.
    Bérard A; Zhao JP; Sheehy O
    BMJ Open; 2017 Jan; 7(1):e013372. PubMed ID: 28082367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depression and antidepressant treatment in the development of hypertensive disorders of pregnancy: Results from a prospective cohort study.
    Galbally M; Watson SJ; Spigset O
    Aust N Z J Psychiatry; 2023 Apr; 57(4):520-527. PubMed ID: 35786007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SSRI and SNRI use during pregnancy and the risk of persistent pulmonary hypertension of the newborn.
    Bérard A; Sheehy O; Zhao JP; Vinet É; Bernatsky S; Abrahamowicz M
    Br J Clin Pharmacol; 2017 May; 83(5):1126-1133. PubMed ID: 27874994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidepressant use during pregnancy and the risk of developing gestational hypertension: a retrospective cohort study.
    Zakiyah N; Ter Heijne LF; Bos JH; Hak E; Postma MJ; Schuiling-Veninga CCM
    BMC Pregnancy Childbirth; 2018 May; 18(1):187. PubMed ID: 29843629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Panic Disorder, Generalized Anxiety Disorder, and Benzodiazepine Treatment During Pregnancy With Risk of Adverse Birth Outcomes.
    Yonkers KA; Gilstad-Hayden K; Forray A; Lipkind HS
    JAMA Psychiatry; 2017 Nov; 74(11):1145-1152. PubMed ID: 28903165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal exposure to selective serotonin reuptake inhibitors and childhood overweight at 7 years of age.
    Grzeskowiak LE; Gilbert AL; Sørensen TI; Olsen J; Sørensen HT; Pedersen LH; Morrison JL
    Ann Epidemiol; 2013 Nov; 23(11):681-7. PubMed ID: 24113367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prenatal exposure to selective serotonin reuptake inhibitors and serotonin norepinephrine reuptake inhibitors and risk for persistent pulmonary hypertension of the newborn: a systematic review, meta-analysis, and network meta-analysis.
    Masarwa R; Bar-Oz B; Gorelik E; Reif S; Perlman A; Matok I
    Am J Obstet Gynecol; 2019 Jan; 220(1):57.e1-57.e13. PubMed ID: 30170040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antidepressant use during pregnancy and the risk of pregnancy-induced hypertension.
    De Vera MA; Bérard A
    Br J Clin Pharmacol; 2012 Aug; 74(2):362-9. PubMed ID: 22435711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attention-deficit/hyperactivity disorder in children following prenatal exposure to antidepressants: results from the Norwegian mother, father and child cohort study.
    Lupattelli A; Mahic M; Handal M; Ystrom E; Reichborn-Kjennerud T; Nordeng H
    BJOG; 2021 Nov; 128(12):1917-1927. PubMed ID: 33982858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased postpartum haemorrhage, the possible relation with serotonergic and other psychopharmacological drugs: a matched cohort study.
    Heller HM; Ravelli ACJ; Bruning AHL; de Groot CJM; Scheele F; van Pampus MG; Honig A
    BMC Pregnancy Childbirth; 2017 Jun; 17(1):166. PubMed ID: 28577352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neonatal and childhood neurodevelopmental, health and educational outcomes of children exposed to antidepressants and maternal depression during pregnancy: protocol for a retrospective population-based cohort study using linked administrative data.
    Singal D; Brownell M; Chateau D; Ruth C; Katz LY
    BMJ Open; 2016 Nov; 6(11):e013293. PubMed ID: 27899401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obstetrical and neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitors: the relevance of dose.
    Roca A; Garcia-Esteve L; Imaz ML; Torres A; Hernández S; Botet F; Gelabert E; Subirà S; Plaza A; Valdés M; Martin-Santos R
    J Affect Disord; 2011 Dec; 135(1-3):208-15. PubMed ID: 21890210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neonatal outcomes after late-gestation exposure to selective serotonin reuptake inhibitors.
    Grzeskowiak LE; Gilbert AL; Morrison JL
    J Clin Psychopharmacol; 2012 Oct; 32(5):615-21. PubMed ID: 22926594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression.
    Nulman I; Koren G; Rovet J; Barrera M; Pulver A; Streiner D; Feldman B
    Am J Psychiatry; 2012 Nov; 169(11):1165-74. PubMed ID: 23128923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn.
    Chambers CD; Hernandez-Diaz S; Van Marter LJ; Werler MM; Louik C; Jones KL; Mitchell AA
    N Engl J Med; 2006 Feb; 354(6):579-87. PubMed ID: 16467545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antidepressant use during pregnancy and the risk of gestational diabetes mellitus: a nested case-control study.
    Dandjinou M; Sheehy O; Bérard A
    BMJ Open; 2019 Oct; 9(9):e025908. PubMed ID: 31575566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Selective Serotonin Reuptake Inhibitor Exposure During Pregnancy With Speech, Scholastic, and Motor Disorders in Offspring.
    Brown AS; Gyllenberg D; Malm H; McKeague IW; Hinkka-Yli-Salomäki S; Artama M; Gissler M; Cheslack-Postava K; Weissman MM; Gingrich JA; Sourander A
    JAMA Psychiatry; 2016 Nov; 73(11):1163-1170. PubMed ID: 27732704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.